Weiss Asset Management LP Agios Pharmaceuticals, Inc. Transaction History

Weiss Asset Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$42.73 - $76.53 $318,851 - $571,066	-7,462 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$71.67 - $91.95 $54,325 - $69,698	-758 Reduced 9.22%	7,462 $575,000
Q2 2018 Aug 13, 2018	BUY	$73.22 - $99.55 $55,500 - $75,458	758 Added 10.16%	8,220 $692,000
Q4 2017 Feb 14, 2018	BUY	$52.12 - $72.33 $232,715 - $322,953	4,465 Added 148.98%	7,462 $427,000
Q3 2017 Nov 14, 2017	BUY	$54.89 - $67.12 $164,505 - $201,158	2,997	2,997 $200,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Weiss Asset Management LP, based on Form 13F filings with the SEC.

Stay updated on Weiss Asset Management LP with notifications on news.